R. Tannouri

Honeywell (France)

Papers

1

Total Citations

41

H-Index

1

About

Dr. R. Tannouri is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) and advanced image-guided treatment delivery. Their most cited work, a 2019 study on fiducial marker implantation for robotic SBRT, has garnered 41 citations and stands as a cornerstone in the field. This seminal research rigorously assessed the feasibility, efficacy, and safety of fiducial tracking using the CyberKnife® system for extracranial tumors, establishing a critical protocol that enhances tumor targeting precision while minimizing toxicity to surrounding healthy tissue. By demonstrating the reliability of this technique, Dr. Tannouri’s contributions have directly improved the standard of care for patients undergoing high-dose, ablative radiotherapy. Their work is widely referenced by clinicians and researchers seeking to optimize motion management in SBRT, underscoring its practical impact on treatment planning and patient outcomes. Through this landmark study and ongoing investigations, Dr. Tannouri continues to shape the evolution of non-invasive cancer therapies, bridging the gap between technological innovation and clinical application.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
41 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Honeywell (France)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago